The global gastroesophageal reflux disease therapeutics market is estimated to be valued at USD 4,986.2 million in 2025 and is projected to reach USD 7,033.5 million by 2035, registering a compound ...

A team led by researchers at Baylor College of Medicine and Washington University School of Medicine has shed light on the ...

OSWEGO – The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to an innovative laboratory test — TissueCypher — that can help ...

EoE is a common immune/antigen-mediated oesophageal disease characterised clinically by symptoms of oesophageal dysfunction and histologically, by eosinophil predominant inflammation. 154 First ...

In Barrett's esophagus, normal esophageal squamous epithelium is replaced by a specialized columnar epithelium. [1] The condition is widespread and incurs patients with a 125-fold greater risk of ...

Indeed, Barrett's mucosa express more CCK2 receptors than normal squamous mucosa [23, 24] and it has also been shown that gastrin exposure increases proliferation in an esophageal cancer cell ...